AISAP presented five clinical studies at the ESC 2026 conference, each led by a clinical champion.

AISAP LTD, located in New York and Tel Aviv, is the brainchild of a multidisciplinary team of AI & Deep learning top-notch experts and leading physicians with deep clinical and research expertise. The AISAP platform is a high-performance AI solution for real-time diagnosis, interpretation, storing, and reporting of ultrasound studies at the point of care. We believe the ultimate combination between advanced technology and clinical professionalism will bring a new vision to change the way we practice medicine today. Using state-of-the-art AI capabilities, we aim to transform the daily interface between physician and patient at the point of care and enable advanced medicine to be accessible to more people in need. AISAP’s POCAD(TM) intuitive and secure SaaS platform is designed to empower healthcare providers by streamlining diagnosis processes, enhancing clinical efficiency, and improving patient outcomes. The AISAP platform generates reliable and validated assessments early in the patient evaluation process and whenever needed during the course of therapy. It is a vendor-agnostic, scalable solution that seamlessly integrates into the clinical workflow, as well as existing EHR/EMR and PACS systems. The software generates accurate reports in minutes using inexpensive devices, enabling emergency medicine, critical care, internal medicine, hospitalists and primary care physicians to make informed care decisions at the bedside.

Founded 2022